Terns Pharmaceuticals Inc (TERN) stock saw a decline, ending the day at $10.02 which represents a decrease of $-0.02 or -0.20% from the prior close of $10.04. The stock opened at $10.25 and touched a ...
加利福尼亚州FOSTER CITY - 专注于开发肿瘤和肥胖症治疗方法的生物制药公司Terns Pharmaceuticals, Inc. (NASDAQ:TERN)今天宣布计划通过公开发行普通股和预付认股权证筹集1.25亿美元。该公司还计划向承销商提供30天期权,以购买价值高达1875万美元的额外股份。
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see a ...